Brenipatide
DrugAdministered SC
Other names: LY3537031
NCT Number: NCT07286175
The purpose of this study is to assess the efficacy and safety of brenipatide when administered with standard of care (SoC), compared with placebo plus SoC in delaying the worsening of bipolar disorder symptoms.
The trial is divided into three periods as follows: Screening period that will last approximately 1 month, treatment period that will last a minimum of 6 months, and the follow up period that will last approximately 2 months. The duration of study participation may vary and may be shortened if bipolar symptoms worsen or if withdrawal from the study occurs for any reason.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Phase 2
Hospital Italiano de Buenos Aires, ABB, Argentina
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Administered SC
Other names: LY3537031
Administered SC
Time frame: Randomization up to at least 6 months
Time frame: Baseline, up to at least 6 months
Time frame: Baseline, up to at least 6 months
Time frame: Baseline, up to at least 6 months
Time frame: Baseline, up to at least 6 months
Time frame: Baseline, up to at least 6 months
Time frame: Baseline, up to at least 6 months
Time frame: Baseline, up to at least 6 months
Time frame: Baseline, up to at least 6 months
Time frame: Baseline, up to at least 6 months
Contact information is provided by the study sponsor or research team.
Physicians interested in becoming principal investigators please contact
CONTACT
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
CONTACT
Eli Lilly and Company
Industry
A Phase 2, Multicenter, Randomized, Double-Blind, Parallel-Arm Study to Investigate the Efficacy and Safety of Adjunctive Treatment With Brenipatide in Delaying Time to Relapse Compared With Placebo in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00024635
Anxiety Disorders, Behavior
Bethesda, Maryland, United States
View Trial DetailsNCT07411222
Behavior, Bipolar Disorder
Bolu, Turkey (Türkiye)
View Trial DetailsNCT07534475
Bipolar Disorder, Bipolar and Related Disorders
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05064319
Bipolar Disorder, Bipolar I Disorder
Charleston, South Carolina, United States
View Trial Details